• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, October 10, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

IN-PEACE tackles burdensome symptoms, challenges of dementia for patients and caregivers

Bioengineer by Bioengineer
October 25, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Regenstrief Institute

INDIANAPOLIS – Individuals with dementia often experience burdensome symptoms such as agitation, aggression, anxiety and pain, but have difficulty with comprehension and communication, making it challenging for healthcare providers to provide appropriate treatment.

With the goals of improving care for symptom management and other burdens of dementia as well as empowering their family caregivers, researchers from the Regenstrief Institute and Indiana University Center for Aging Research are integrating state of the art dementia care with palliative care through an innovative supportive care model they have named IN-PEACE. The initiative is funded by a new $3.5 million grant from the National Institute on Aging.

"Dementia has become one of the leading causes of death in the U.S., overtaking many of the chronic conditions that people typically think of as leading causes of death," said Regenstrief Institute and IU Center for Aging Research investigator Greg Sachs, M.D., who designed and leads IN-PEACE. "We believe IN-PEACE will reshape how care is provided to people with dementia and their families, especially in the later stages of the illness."

IN-PEACE is the first randomized controlled trial that simultaneously targets patient symptoms, caregiver mood and distress as well as the reduction of burdensome and potentially unnecessary treatments for community dwellers with dementia. IN-PEACE provides support by nurses and social workers for both decisionmaking and transitions in care.

"Neuropsychiatric symptoms like agitation, aggression, anxiety, and repetitive behaviors are too often treated with medications which produce greater adverse effects than benefits for individuals with dementia," said Dr. Sachs. "We have designed IN-PEACE to focus on these neuropsychiatric symptoms, as well as to recognize and sort out if someone is having pain and to treat these burdens of dementia earlier and more effectively."

"As we treat discomfort and other significant hardships in the individual with dementia, we are working with family caregivers to lower their stress and hopefully see less depression in these spouses, daughters, daughters-in-law and others who are bearing such a tremendous burden." Dr. Sachs, an internationally respected leader in geriatrics and palliative care, directs IU School of Medicine's Division of General Internal Medicine and Geriatrics.

IN-PEACE is an acronym for Indiana Palliative Excellence in Alzheimer's Care Efforts. Palliative care, which focuses on providing relief from the symptoms and stress of a serious illness by understanding and meeting a patient's preferences and goals, can be extended to patients with any serious illness. Palliative care, though frequently provided to cancer patients, is far less often offered to patients with dementia to help them and their families navigate the course of this severe, and often lengthy, illness.

IN-PEACE will enroll 200 patients from throughout central Indiana with Alzheimer's disease and other dementias including cognitive impairment from Parkinson's disease and stroke in addition to their 200 caregivers. Each patient-caregiver pair will be randomized to usual or enhanced care. Outcomes of the two groups will be compared.

Usual care will consist of the primary care and any specialty care that the dementia patient and family member is already receiving in their community. Enhanced care recipients will receive usual care plus an additional layer of support spearheaded by a nurse or social worker who will maintain regular in-person and phone contact with the patient and caregiver, conduct routine assessments of anxiety, pain and other symptoms and intervene rapidly rather than waiting for the individual to come to his or her physician's office or to go to a hospital emergency department.

Although the onset of cognitive impairment can occur at any age, risk for dementia increases with age. The U.S. is getting older, and the Census Bureau reports that in 2015, nearly 15 percent of the U.S. population was 65 or older.

###

In addition to Dr. Sachs, IN-PEACE co-investigators include Alexia Torke, M.D., and Kurt Kroenke, M.D., both of the Regenstrief Institute and IU School of Medicine; Mary Guerriero Austrom, Ph.D. of the Indiana Alzheimer Disease Center and IU School of Medicine; Sujuan Gao, Ph.D. of IU School of Medicine and Susan Hickman, Ph.D. of IU School of Nursing, Dr. Sachs describes them as an all-star team with expertise in palliative care symptom management, family caregiving and biostatistics.

IN-PEACE will enroll its first patients and caregivers in January 2019. Study participants will be referred to IN-PEACE by the Central Indiana physicians the patient routinely sees.

Media Contact

Cindy Fox Aisen
[email protected]
317-843-2275
@regenstrief

Home Page

Share12Tweet7Share2ShareShareShare1

Related Posts

Creating a Canadian Midwifery Research Priority Framework

October 10, 2025

Boosting Balance in Seniors: Innovative VR and Stimulation Trial

October 10, 2025

Sensitive Near-Point Detection of Hidden Malaria Infections

October 10, 2025

SARS-CoV-2 Impacts Children with Nephrotic Syndrome

October 10, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1189 shares
    Share 475 Tweet 297
  • New Study Reveals the Science Behind Exercise and Weight Loss

    101 shares
    Share 40 Tweet 25
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    96 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    82 shares
    Share 33 Tweet 21

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Thermostable Enzymes Generating Superoxide Radicals Isolated

Creating a Canadian Midwifery Research Priority Framework

AI-Driven Fuzzy Evaluation of English Teaching Quality

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.